Secondary malignant neoplasm of liver and intrahepatic bile duct. C78. 7 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
C22. 0 - Liver cell carcinoma | ICD-10-CM.
Primary liver cancer is classified to ICD-9-CM code 155.0. Secondary liver cancer, also called metastasis to the liver, is classified to code 197.7. If liver cancer is documented with no further specification stating primary or secondary, assign code 155.2.
ICD-10 Code for Secondary malignant neoplasm of unspecified site- C79. 9- Codify by AAPC.
If the site of the primary cancer is not documented, the coder will assign a code for the metastasis first, followed by C80. 1 malignant (primary) neoplasm, unspecified. For example, if the patient was being treated for metastatic bone cancer, but the primary malignancy site is not documented, assign C79. 51, C80.
10 for Atherosclerotic heart disease of native coronary artery without angina pectoris is a medical classification as listed by WHO under the range - Diseases of the circulatory system .
Liver metastases are cancerous tumors that have spread (metastasized) to the liver from another part of the body. These tumors can appear shortly after the original tumor develops, or even months or years later. This information is about cancer that has spread to the liver.
ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10 code C79. 51 for Secondary malignant neoplasm of bone is a medical classification as listed by WHO under the range - Malignant neoplasms .
Secondary malignant neoplasm of other specified sites C79. 89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C79. 89 became effective on October 1, 2021.
Metastatic cancer has the same name as the primary cancer. For example, breast cancer that spreads to the lung is called metastatic breast cancer, not lung cancer. It is treated as stage IV breast cancer, not as lung cancer.
The primary site is to be sequenced first, followed by any metastatic sites. When an encounter is for a primary malignancy with metastasis and treatment is directed toward the metastatic (secondary) site(s) only, the metastatic site(s) is designated as the principal/first-listed diagnosis.